Macquarie Group LTD Iovance Biotherapeutics, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 3,190,036 shares of IOVA stock, worth $23.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,190,036
Holding current value
$23.5 Million
% of portfolio
0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.28 - $11.9 $23.2 Million - $38 Million
3,190,036 New
3,190,036 $30 Million
Q1 2024

May 14, 2024
BUY
$7.59 - $17.47 $926,382 - $2.13 Million
122,053 New
122,053 $1.81 Million
Q1 2023

May 15, 2023
SELL
$5.53 - $8.22 $3,727 - $5,540
-674 Reduced 1.19%
55,835 $341,000
Q4 2022

Feb 21, 2023
SELL
$5.62 - $10.0 $41,290 - $73,470
-7,347 Reduced 11.51%
56,509 $361,000
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $24,177 - $33,260
-2,537 Reduced 3.82%
63,856 $634,000
Q2 2022

Aug 15, 2022
BUY
$6.38 - $18.33 $10,979 - $31,545
1,721 Added 2.66%
66,393 $733,000
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $86,895 - $134,062
7,019 Added 12.17%
64,672 $1.08 Million
Q4 2021

Feb 11, 2022
BUY
$16.55 - $27.63 $156,761 - $261,711
9,472 Added 19.66%
57,653 $1.1 Million
Q3 2021

Nov 12, 2021
SELL
$20.35 - $26.63 $34,595 - $45,271
-1,700 Reduced 3.41%
48,181 $1.19 Million
Q2 2021

Aug 13, 2021
BUY
$16.33 - $33.07 $103,581 - $209,763
6,343 Added 14.57%
49,881 $1.3 Million
Q1 2021

May 14, 2021
BUY
$28.67 - $52.59 $132,140 - $242,387
4,609 Added 11.84%
43,538 $1.38 Million
Q4 2020

Feb 16, 2021
SELL
$28.04 - $50.26 $337,769 - $605,431
-12,046 Reduced 23.63%
38,929 $1.81 Million
Q3 2020

Nov 13, 2020
SELL
$27.75 - $36.3 $32,994 - $43,160
-1,189 Reduced 2.28%
50,975 $1.68 Million
Q2 2020

Aug 11, 2020
BUY
$27.21 - $41.0 $185,272 - $279,169
6,809 Added 15.01%
52,164 $1.43 Million
Q1 2020

May 15, 2020
SELL
$19.54 - $38.85 $315,316 - $626,922
-16,137 Reduced 26.24%
45,355 $1.36 Million
Q4 2019

Feb 14, 2020
SELL
$17.95 - $29.41 $38,269 - $62,702
-2,132 Reduced 3.35%
61,492 $1.7 Million
Q3 2019

Nov 14, 2019
BUY
$17.99 - $26.0 $611 - $884
34 Added 0.05%
63,624 $1.16 Million
Q2 2019

Aug 14, 2019
SELL
$9.78 - $24.52 $133,203 - $333,962
-13,620 Reduced 17.64%
63,590 $1.56 Million
Q1 2019

May 15, 2019
BUY
$8.41 - $11.26 $649,336 - $869,384
77,210 New
77,210 $734,000

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
237M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.16B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email